195 related articles for article (PubMed ID: 33118859)
21. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike.
Liu L; Wang P; Nair MS; Yu J; Rapp M; Wang Q; Luo Y; Chan JF; Sahi V; Figueroa A; Guo XV; Cerutti G; Bimela J; Gorman J; Zhou T; Chen Z; Yuen KY; Kwong PD; Sodroski JG; Yin MT; Sheng Z; Huang Y; Shapiro L; Ho DD
Nature; 2020 Aug; 584(7821):450-456. PubMed ID: 32698192
[TBL] [Abstract][Full Text] [Related]
22. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].
Lvov DK; Alkhovsky SV
Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561
[TBL] [Abstract][Full Text] [Related]
23. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
[TBL] [Abstract][Full Text] [Related]
24. Pooling of samples for testing for SARS-CoV-2 in asymptomatic people.
Lohse S; Pfuhl T; Berkó-Göttel B; Rissland J; Geißler T; Gärtner B; Becker SL; Schneitler S; Smola S
Lancet Infect Dis; 2020 Nov; 20(11):1231-1232. PubMed ID: 32530425
[No Abstract] [Full Text] [Related]
25. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.
Chi X; Yan R; Zhang J; Zhang G; Zhang Y; Hao M; Zhang Z; Fan P; Dong Y; Yang Y; Chen Z; Guo Y; Zhang J; Li Y; Song X; Chen Y; Xia L; Fu L; Hou L; Xu J; Yu C; Li J; Zhou Q; Chen W
Science; 2020 Aug; 369(6504):650-655. PubMed ID: 32571838
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 infection protects against rechallenge in rhesus macaques.
Chandrashekar A; Liu J; Martinot AJ; McMahan K; Mercado NB; Peter L; Tostanoski LH; Yu J; Maliga Z; Nekorchuk M; Busman-Sahay K; Terry M; Wrijil LM; Ducat S; Martinez DR; Atyeo C; Fischinger S; Burke JS; Slein MD; Pessaint L; Van Ry A; Greenhouse J; Taylor T; Blade K; Cook A; Finneyfrock B; Brown R; Teow E; Velasco J; Zahn R; Wegmann F; Abbink P; Bondzie EA; Dagotto G; Gebre MS; He X; Jacob-Dolan C; Kordana N; Li Z; Lifton MA; Mahrokhian SH; Maxfield LF; Nityanandam R; Nkolola JP; Schmidt AG; Miller AD; Baric RS; Alter G; Sorger PK; Estes JD; Andersen H; Lewis MG; Barouch DH
Science; 2020 Aug; 369(6505):812-817. PubMed ID: 32434946
[TBL] [Abstract][Full Text] [Related]
27. We shouldn't worry when a virus mutates during disease outbreaks.
Grubaugh ND; Petrone ME; Holmes EC
Nat Microbiol; 2020 Apr; 5(4):529-530. PubMed ID: 32071422
[TBL] [Abstract][Full Text] [Related]
28. The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19.
Yoshimoto FK
Protein J; 2020 Jun; 39(3):198-216. PubMed ID: 32447571
[TBL] [Abstract][Full Text] [Related]
29. Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays.
Hyseni I; Molesti E; Benincasa L; Piu P; Casa E; Temperton NJ; Manenti A; Montomoli E
Viruses; 2020 Sep; 12(9):. PubMed ID: 32927639
[TBL] [Abstract][Full Text] [Related]
30. An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection.
Conzelmann C; Gilg A; Groß R; Schütz D; Preising N; Ständker L; Jahrsdörfer B; Schrezenmeier H; Sparrer KMJ; Stamminger T; Stenger S; Münch J; Müller JA
Antiviral Res; 2020 Sep; 181():104882. PubMed ID: 32738255
[TBL] [Abstract][Full Text] [Related]
31. Prediction and evolution of B cell epitopes of surface protein in SARS-CoV-2.
Lon JR; Bai Y; Zhong B; Cai F; Du H
Virol J; 2020 Oct; 17(1):165. PubMed ID: 33121513
[TBL] [Abstract][Full Text] [Related]
32. Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients.
Andrés C; Garcia-Cehic D; Gregori J; Piñana M; Rodriguez-Frias F; Guerrero-Murillo M; Esperalba J; Rando A; Goterris L; Codina MG; Quer S; Martín MC; Campins M; Ferrer R; Almirante B; Esteban JI; Pumarola T; Antón A; Quer J
Emerg Microbes Infect; 2020 Dec; 9(1):1900-1911. PubMed ID: 32752979
[TBL] [Abstract][Full Text] [Related]
33. Establishment of replication-competent vesicular stomatitis virus-based recombinant viruses suitable for SARS-CoV-2 entry and neutralization assays.
Li H; Zhao C; Zhang Y; Yuan F; Zhang Q; Shi X; Zhang L; Qin C; Zheng A
Emerg Microbes Infect; 2020 Dec; 9(1):2269-2277. PubMed ID: 32990161
[TBL] [Abstract][Full Text] [Related]
34. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.
Korber B; Fischer WM; Gnanakaran S; Yoon H; Theiler J; Abfalterer W; Hengartner N; Giorgi EE; Bhattacharya T; Foley B; Hastie KM; Parker MD; Partridge DG; Evans CM; Freeman TM; de Silva TI; ; McDanal C; Perez LG; Tang H; Moon-Walker A; Whelan SP; LaBranche CC; Saphire EO; Montefiori DC
Cell; 2020 Aug; 182(4):812-827.e19. PubMed ID: 32697968
[TBL] [Abstract][Full Text] [Related]
35. Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction.
Lau SY; Wang P; Mok BW; Zhang AJ; Chu H; Lee AC; Deng S; Chen P; Chan KH; Song W; Chen Z; To KK; Chan JF; Yuen KY; Chen H
Emerg Microbes Infect; 2020 Dec; 9(1):837-842. PubMed ID: 32301390
[TBL] [Abstract][Full Text] [Related]
36. Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques.
Shan C; Yao YF; Yang XL; Zhou YW; Gao G; Peng Y; Yang L; Hu X; Xiong J; Jiang RD; Zhang HJ; Gao XX; Peng C; Min J; Chen Y; Si HR; Wu J; Zhou P; Wang YY; Wei HP; Pang W; Hu ZF; Lv LB; Zheng YT; Shi ZL; Yuan ZM
Cell Res; 2020 Aug; 30(8):670-677. PubMed ID: 32636454
[TBL] [Abstract][Full Text] [Related]
37. Emerging genetic diversity among clinical isolates of SARS-CoV-2: Lessons for today.
Sheikh JA; Singh J; Singh H; Jamal S; Khubaib M; Kohli S; Dobrindt U; Rahman SA; Ehtesham NZ; Hasnain SE
Infect Genet Evol; 2020 Oct; 84():104330. PubMed ID: 32335334
[TBL] [Abstract][Full Text] [Related]
38. Functional Pangenome Analysis Shows Key Features of E Protein Are Preserved in SARS and SARS-CoV-2.
Alam I; Kamau AA; Kulmanov M; Jaremko Ł; Arold ST; Pain A; Gojobori T; Duarte CM
Front Cell Infect Microbiol; 2020; 10():405. PubMed ID: 32850499
[TBL] [Abstract][Full Text] [Related]
39. Immunoinformatic analysis of the SARS-CoV-2 envelope protein as a strategy to assess cross-protection against COVID-19.
Tilocca B; Soggiu A; Sanguinetti M; Babini G; De Maio F; Britti D; Zecconi A; Bonizzi L; Urbani A; Roncada P
Microbes Infect; 2020; 22(4-5):182-187. PubMed ID: 32446902
[TBL] [Abstract][Full Text] [Related]
40. High-Density Amplicon Sequencing Identifies Community Spread and Ongoing Evolution of SARS-CoV-2 in the Southern United States.
McNamara RP; Caro-Vegas C; Landis JT; Moorad R; Pluta LJ; Eason AB; Thompson C; Bailey A; Villamor FCS; Lange PT; Wong JP; Seltzer T; Seltzer J; Zhou Y; Vahrson W; Juarez A; Meyo JO; Calabre T; Broussard G; Rivera-Soto R; Chappell DL; Baric RS; Damania B; Miller MB; Dittmer DP
Cell Rep; 2020 Nov; 33(5):108352. PubMed ID: 33113345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
